Bio-Rad Laboratories Inc (BIO)
281.74
+1.91
(+0.68%)
USD |
NYSE |
May 06, 16:00
281.74
0.00 (0.00%)
After-Hours: 20:00
Bio-Rad Laboratories Cash from Investing (TTM): 20.21M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 20.21M |
| September 30, 2023 | -110.54M |
| June 30, 2023 | -189.46M |
| March 31, 2023 | -361.92M |
| December 31, 2022 | -1.208B |
| September 30, 2022 | -1.716B |
| June 30, 2022 | -1.709B |
| March 31, 2022 | -1.665B |
| December 31, 2021 | -797.38M |
| September 30, 2021 | -289.71M |
| June 30, 2021 | -117.50M |
| March 31, 2021 | -105.80M |
| December 31, 2020 | -69.89M |
| September 30, 2020 | -71.34M |
| June 30, 2020 | -272.10M |
| March 31, 2020 | -198.60M |
| December 31, 2019 | -208.89M |
| September 30, 2019 | -202.50M |
| June 30, 2019 | -122.10M |
| March 31, 2019 | -190.88M |
| December 31, 2018 | -186.98M |
| September 30, 2018 | -145.25M |
| June 30, 2018 | -130.56M |
| March 31, 2018 | -84.00M |
| December 31, 2017 | -175.57M |
| Date | Value |
|---|---|
| September 30, 2017 | -212.61M |
| June 30, 2017 | -251.23M |
| March 31, 2017 | -273.41M |
| December 31, 2016 | -213.88M |
| September 30, 2016 | -247.54M |
| June 30, 2016 | -221.34M |
| March 31, 2016 | -189.74M |
| December 31, 2015 | -166.87M |
| September 30, 2015 | -132.54M |
| June 30, 2015 | -151.81M |
| March 31, 2015 | -182.93M |
| December 31, 2014 | -190.51M |
| September 30, 2014 | -180.51M |
| June 30, 2014 | 40.93M |
| March 31, 2014 | 73.63M |
| December 31, 2013 | 0.919M |
| September 30, 2013 | -19.26M |
| June 30, 2013 | -298.11M |
| March 31, 2013 | -422.38M |
| December 31, 2012 | -400.39M |
| September 30, 2012 | -513.21M |
| June 30, 2012 | -465.09M |
| March 31, 2012 | -395.32M |
| December 31, 2011 | -386.33M |
| September 30, 2011 | -265.99M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-1.716B
Minimum
Sep 2022
20.21M
Maximum
Dec 2023
-494.54M
Average
-202.50M
Median
Sep 2019
Cash from Investing (TTM) Benchmarks
| Agilent Technologies Inc | -301.00M |
| Bruker Corp | -522.00M |
| Azenta Inc | 473.42M |
| Harvard Bioscience Inc | -1.799M |
| Bionano Genomics Inc | 24.16M |